The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) firmly enshrined a legal framework guaranteeing enforceable minimum intellectual property (IP) standards at the international level. But it also resulted in a greater inclusion of intellectual property rights (IPRs) in wider political debates between developing and industrialised countries – for instance on questions of global health and development. This paper argues that the increasing reach and efficacy of the IP regime has given rise to wider challenges to the IP system needing urgent conceptual analysis. The focus here is on IP’s increasing confrontation with the right to health, which is analysed not as an encounter of radically opposed legal systems, but a...
This article discusses the human right to health in the context of patent protection and access to m...
Public health literature has long recognized the existence of determinants of health, a set of socio...
1. Pharmaceutical patents, the access to essential medicines and the question of innovation - 2. The...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The question posed in this article is whether the right to health and patents conflict or coexist. T...
This article aims to provide a brief overview of the Agreement of Trade-Related Aspects of Intellect...
The non-effectiveness of certain codified human rights is particularly apparent with reference to th...
This article discusses the human right to health in the context of patent protection and access to m...
Intellectual property rights (IPRs) are about wealth and about who owns and controls knowledge. IPRs...
Intellectual property rights (IPRs) are privatised in the TRIPS Agreement. In such premise, these pr...
Intellectual property laws bestow a time bound individual right to a right holder, which after a cer...
In this introduction we briefly review the literature on intellectual property rights and access to ...
The history of patent harmonization is a story of dynamic actors, whose interactions with establishe...
Any system for the protection of intellectual property rights (IPRs) has three main kinds of distrib...
Few issues are as controversial as the impact of intellectual property on health in developing count...
This article discusses the human right to health in the context of patent protection and access to m...
Public health literature has long recognized the existence of determinants of health, a set of socio...
1. Pharmaceutical patents, the access to essential medicines and the question of innovation - 2. The...
The coming into force of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRI...
The question posed in this article is whether the right to health and patents conflict or coexist. T...
This article aims to provide a brief overview of the Agreement of Trade-Related Aspects of Intellect...
The non-effectiveness of certain codified human rights is particularly apparent with reference to th...
This article discusses the human right to health in the context of patent protection and access to m...
Intellectual property rights (IPRs) are about wealth and about who owns and controls knowledge. IPRs...
Intellectual property rights (IPRs) are privatised in the TRIPS Agreement. In such premise, these pr...
Intellectual property laws bestow a time bound individual right to a right holder, which after a cer...
In this introduction we briefly review the literature on intellectual property rights and access to ...
The history of patent harmonization is a story of dynamic actors, whose interactions with establishe...
Any system for the protection of intellectual property rights (IPRs) has three main kinds of distrib...
Few issues are as controversial as the impact of intellectual property on health in developing count...
This article discusses the human right to health in the context of patent protection and access to m...
Public health literature has long recognized the existence of determinants of health, a set of socio...
1. Pharmaceutical patents, the access to essential medicines and the question of innovation - 2. The...